MedPath

Natamycin

Generic Name
Natamycin
Brand Names
Natacyn
Drug Type
Small Molecule
Chemical Formula
C33H47NO13
CAS Number
7681-93-8
Unique Ingredient Identifier
8O0C852CPO

Overview

Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem]

Indication

For the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.

Associated Conditions

  • Fungal blepharitis
  • Fungal conjunctivitis
  • Fungal infections of the cornea

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Eyevance Pharmaceuticals, LLC
71776-005
OPHTHALMIC
50 mg in 1 mL
10/9/2023

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
NATACYN 5% STERILE OPHTHALMIC SUSPENSION
SIN06719P
SOLUTION
5%
12/9/1991

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Natamycin Eye Drops
国药准字H20083292
化学药品
滴眼剂
1/29/2023
Natamycin Eye Drops
国药准字H20083650
化学药品
眼用制剂
8/5/2022
Natamycin Eye Drops
国药准字H20073918
化学药品
眼用制剂
8/5/2022
Natamycin Eye Drops
国药准字H20083293
化学药品
滴眼剂
1/29/2023

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.